Oral administration of β-cryptoxanthin prevents bone loss in streptozotocin-diabetic rats in Vivo

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 9, 2005, Pages 1766-1769

  Uchiyama, Satoshi ^a   Yamaguchi, Masayoshi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA CRYPTOXANTHIN; CALCIUM; CAROTENOID; DNA; GLUCOSE; STREPTOZOCIN; TRIACYLGLYCEROL;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEFECT; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DIAPHYSIS; DNA CONTENT; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMUR; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; MALE; METAPHYSIS; NONHUMAN; OSTEOLYSIS; OSTEOPOROSIS; PROPHYLAXIS; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ANIMALS; BETA CAROTENE; BLOOD GLUCOSE; BODY WEIGHT; BONE RESORPTION; CALCIUM; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; FEMUR; MALE; PHOSPHATES; RATS; RATS, WISTAR; TRIGLYCERIDES; XANTHOPHYLLS;

EID: 24944449444     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1766     Document Type: Article

References (28)

1. Schapiua C., Slinn S., Sarid M., Mokadai S., Kabala A., Slibermann M., Bone, 16, 575-582 (1995).
2. Wild R. A., Buchamain J. R., Meyers C., Demers L. M., Proc. Soc. Exp. Biol. Med., 186, 335-360 (1987).
3. Cooper C., Melton J., III, Trends Endocrinol. Metab., 3, 224-229 (1992).
4. Bonjour J.-P., Schurch M.-A., Rizzori R., Bone, 18, 1395-1445 (1996).
5. Yamaguchi M., J. Health Sci., 48, 209-222 (2002).
6. Steinmetz K. A., Potter J. D., J. Am. Diet. Assoc., 96, 1027-1033 (1996).
7. Forsyth K. A., Watoson R. R., Gensler H. L., Life Sci., 45, 2149-2156 (1989).
8. Rokde C. M., Manatt M., Clagett-Dome M., DeLuca H. F., J. Nutr., 129, 2241-2250 (1999).
9. Promislow J. H. E., Goodman-Gruen D., Slymen D. J., Burret-Connor E., J. Bone Miner. Res., 17, 1349-1358 (2002).
10. Yamaguchi M., Uchiyama S., Biol. Pharm. Bull., 26, 1188-1191 (2003).
11. Yamaguchi M., Uchiyama S., Mol. Cell. Biochem., 258, 137-144 (2004).
12. Uchiyama S., Yamaguchi M., Int. J. Mol. Med., 15, 675-681 (2005).
13. Uchiyama S., Yamaguchi M., J. Cell. Biochem., 95, 1224-1234 (2005).
14. Uchiyama S., Yamaguchi M., Biochem. Pharmacol., 67, 1297-1305 (2004).
15. Uchiyama S., Sumida T., Yamaguchi M., Biol. Pharm. Bull., 27, 232-235 (2004).
16. Uchiyama S., Sumida T., Yamaguchi M., J. Health Sci., 50, 491-496 (2004).
17. Bollen M., Miralpeix M., Venture F., Toth B., Bartrons R., Stalmans W., Biochem. J., 267, 269-271 (1990).
18. Yamaguchi M., Oishi H., Suketa Y., Biochem. Pharmacol., 36, 4007-4012 (1987).
19. Walter K., Schutt C., "Methods of Enzymatic Analysis," ed. by Bergmeyer H. U., Academic Press, New York, 1965, pp. 856-860.
20. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., J. Biol. Chem., 193, 265-273 (1951).
21. Flanagan B., Nichols G. J., J. Biol. Chem., 237, 3686-3692 (1962).
22. Ceriotti G., J. Biol. Chem., 214, 39-77 (1955).
23. Shires R., Teitelbaum S. L., Bergfedld M. A., Fallom M. D., Slatopolsky E., Avioli L. V., J. Lab. Clin. Med., 97, 231-240 (1981).
24. Bouillon R., Calcif. Tissue Int., 49, 155-160 (1991).
25. Levin M. E., Boisseau V. C., Avioli L.V., N. Engl. J. Med., 294, 241-245 (1976).
26. Majeska R. J., Rodan G. A., J. Biol. Chem., 257, 3362-3365 (1982).
27. Canalis E., Endocrinology, 116, 855-862 (1985).
28. McEligot A. J., Rock C. L., Shanks T. G., Flatt S. W., Newman V., Faerber S., Pierce P., Cancer Epidemiol. Biomark. Prev., 4, 491-496 (1995).